# Which shoulder care can you try first?

*What can help? | shoulder pain treatment mesa*

> Compare shoulder pain treatment Mesa choices, from simple care and rotator cuff physical therapy to PRP or surgery.

What can you try for a sore shoulder before thinking about surgery? Rest the movement that sets it off, but keep the arm gently active. Add strength slowly enough that the next morning isn't worse. That's a sound place to begin.

## What can I change at home?

Notice which reach, lift, or sleeping position brings on the ache. Change that chore for a while instead of testing the shoulder again and again. You can still use the arm for easy work that doesn't cause a sharp catch. If it hurts more the next morning, you probably did too much the day before.

## Could rotator cuff physical therapy help?

Rotator cuff physical therapy uses exercises for the small muscles and tendons that steady your shoulder. The therapist can show you how hard to work and how far to move. The exercise shouldn't cause a sharp catch or leave you much worse the next day. You can judge progress by sleep, dressing, reaching, and lifting.

## When does surgery enter the talk?

A fresh tear, lasting weakness, or a badly worn joint may bring surgery into the talk. Repair joins a torn tendon, while replacement changes the worn parts of the joint. Another operation removes bone and soft tissue above sore tendons, but it hasn't done better than exercise for that broad kind of ache. Any operation brings recovery time, risk, and the need for help at home.

## What if careful home care isn't enough?

If home care isn't enough, QC Kinetix medical providers check your shoulder and discuss regenerative treatment, which means non-surgical care such as platelet-rich plasma, or PRP, prepared there from your blood and put into the sore shoulder. The research isn't equally strong for every kind of soreness. A visit can cover your exam, earlier care, the likely cost, and the work you want to do again. You'll want a plain reason before spending the money.

## Sources

1. In the MOON Shoulder prospective cohort of 452 patients with symptomatic, ATRAUMATIC full-thickness rotator cuff tears, physical therapy succeeded in more than 70% of patients at 10 years: only 115 (27.0%) had surgery at any point over the decade. Patient-reported outcomes improved with physical therapy and did NOT decline over 10 years in those who never had surgery. The strongest predictor of early surgery was low patient expectation of physical therapy, not tear anatomy.
   Kuhn JE, et al. — [The Predictors of Surgery for Symptomatic, Atraumatic Full-Thickness Rotator Cuff Tears Change Over Time: Ten-Year Outcomes of the MOON Shoulder Prospective Cohort.](https://pubmed.ncbi.nlm.nih.gov/38980920/). *J Bone Joint Surg Am*, 2024. DOI: 10.2106/JBJS.23.00978.
2. The GRASP trial randomized 708 adults with a rotator cuff disorder to progressive exercise (up to 6 sessions), a single best-practice advice session, or either of those preceded by a corticosteroid injection. Over 12 months there was no evidence of a difference in Shoulder Pain and Disability Index between progressive exercise and one advice session (adjusted mean difference -0.66, 99% CI -4.52 to 3.20), and no evidence of a difference between having a corticosteroid injection and not having one.
   Hopewell S, et al. — [Progressive exercise compared with best practice advice, with or without corticosteroid injection, for the treatment of patients with rotator cuff disorders (GRASP): a multicentre, pragmatic, 2 × 2 factorial, randomised controlled trial.](https://pubmed.ncbi.nlm.nih.gov/34265255/). *Lancet*, 2021. DOI: 10.1016/S0140-6736(21)00846-1.
3. UK FROST randomized 503 adults with primary frozen shoulder to manipulation under anaesthesia, arthroscopic capsular release, or early structured physiotherapy with steroid injection. At 12 months every between-group difference on the Oxford Shoulder Score was smaller than the target difference, so NONE of the three was clinically superior. Capsular release carried the most serious adverse events (8 versus 2 with manipulation), and manipulation under anaesthesia was the most cost-effective.
   Rangan A, et al. — [Management of adults with primary frozen shoulder in secondary care (UK FROST): a multicentre, pragmatic, three-arm, superiority randomised clinical trial.](https://pubmed.ncbi.nlm.nih.gov/33010843/). *Lancet*, 2020. DOI: 10.1016/S0140-6736(20)31965-6.
4. A 2025 Bayesian network meta-analysis of exercise for rotator cuff-related shoulder pain (15-16 studies, 913-947 participants) ranked CONCENTRIC strengthening training first for both pain and shoulder dysfunction; eccentric and traditional training were moderately effective and significantly better than motor-control and scapula-focused training.
   Zhang W, et al. — [Effects of seven types of exercise in the treatment of rotator cuff-related shoulder pain (RCRSP): a systematic review and Bayesian network meta-analysis.](https://pubmed.ncbi.nlm.nih.gov/41276811/). *J Orthop Surg Res*, 2025. DOI: 10.1186/s13018-025-06514-4.
5. A 2026 meta-analysis of 10 randomized trials (n=591) found PRP and corticosteroid indistinguishable at 3-6 weeks and 3 months, with PRP pulling ahead at 6 months: ASES +10.8 (95% CI 4.71-16.80), Constant-Murley +10.7 (1.21-20.27) and VAS pain -0.8 (-1.45 to -0.18), plus fewer adverse events (RR 0.66, 0.44-0.99). The authors describe the benefit as statistically significant but CLINICALLY MODEST.
   Yuwarungsikul C, et al. — [Platelet-rich plasma provides modest but durable functional benefit over corticosteroid for rotator cuff tendinopathy: A systematic review and meta-analysis of randomized controlled trials.](https://pubmed.ncbi.nlm.nih.gov/42021740/). *Knee Surg Sports Traumatol Arthrosc*, 2026. DOI: 10.1002/ksa.70416.
6. A 2025 systematic review of 1,125 patients receiving intra-articular injections for glenohumeral osteoarthritis reported a 7.2% overall complication rate and a 3.2% rate of proceeding to surgery. Hyaluronic acid showed consistent though modest benefit, while the evidence for ORTHOBIOLOGICS (PRP, bone marrow aspirate concentrate, mesenchymal stem cells) 'remains limited', mainly because of heterogeneity in design, outcomes and patient characteristics.
   Migliorini F, et al. — [Intra-articular injections for shoulder arthritis in adults: a systematic review.](https://pubmed.ncbi.nlm.nih.gov/41204311/). *Eur J Med Res*, 2025. DOI: 10.1186/s40001-025-03423-4.
7. A 2026 meta-analysis of eight level-I randomized trials (452 patients) found SUPRASCAPULAR NERVE BLOCK superior to intra-articular corticosteroid injection for adhesive capsulitis pain at 3-4 weeks (SMD 0.63), 6-7 weeks (SMD 0.49) and 12 weeks (SMD 1.68), and superior on SPADI and active abduction (+14.4 degrees) at 12 weeks. Heterogeneity was considerable for every analysis.
   Harley JD, et al. — [Intra-articular corticosteroid injection vs. suprascapular nerve block for adhesive capsulitis: a systematic review and meta-analysis of level I randomized controlled trials.](https://pubmed.ncbi.nlm.nih.gov/40681086/). *J Shoulder Elbow Surg*, 2026. DOI: 10.1016/j.jse.2025.05.037.
8. A network meta-analysis of 33 randomized trials covering 26 treatments for rotator cuff CALCIFIC tendinitis ranked comprehensive physical therapy first for functional improvement and radial shockwave therapy plus physical therapy first for pain relief. Among surgical options, arthroscopic bursectomy with debridement performed the same as bursectomy plus subacromial decompression, and the review notes there is no direct data comparing operative with non-operative treatment.
   Yao Y, et al. — [Treatments for rotator cuff calcific tendinitis: a systematic review and network meta-analysis of randomized-controlled trials.](https://pubmed.ncbi.nlm.nih.gov/40591667/). *EFORT Open Rev*, 2025. DOI: 10.1530/EOR-2024-0078.
9. At 10 years, arthroscopic subacromial decompression offered NO benefit over placebo surgery for subacromial pain syndrome: the mean difference in VAS pain was -1.5 points (95% CI -8.6 to 5.6) at rest and -3.2 points (-13.0 to 6.5) on arm activity, against a minimally important difference of 15. It also showed no benefit over exercise therapy.
   Kanto K, et al. — [Arthroscopic subacromial decompression versus placebo surgery for subacromial pain syndrome: 10 year follow-up of the FIMPACT randomised, placebo surgery controlled trial.](https://pubmed.ncbi.nlm.nih.gov/41330610/). *BMJ*, 2025. DOI: 10.1136/bmj-2025-086201.
10. At 5 years, FIMPACT still showed no benefit of arthroscopic subacromial decompression over diagnostic arthroscopy: VAS pain differences of -2.0 at rest (95% CI -8.5 to 4.6) and -8.0 on arm activity (-17.3 to 1.3), neither exceeding the minimally important difference, and no advantage over exercise therapy either.
   Paavola M, et al. — [Subacromial decompression versus diagnostic arthroscopy for shoulder impingement: a 5-year follow-up of a randomised, placebo surgery controlled clinical trial.](https://pubmed.ncbi.nlm.nih.gov/33020137/). *Br J Sports Med*, 2021. DOI: 10.1136/bjsports-2020-102216.
11. A systematic review of 87 studies of extra-articular (soft tissue) corticosteroid injection found major adverse events in 0-5.8% and minor adverse events in 0-81% of patients depending on the study. Reported major events included osteomyelitis, cellulitis, tendon ruptures, skin atrophy and hypopigmentation, and one fatal necrotizing fasciitis; increased pain or steroid flare after injection was reported in 19 studies.
   Brinks A, et al. — [Adverse effects of extra-articular corticosteroid injections: a systematic review.](https://pubmed.ncbi.nlm.nih.gov/20836867/). *BMC Musculoskelet Disord*, 2010. DOI: 10.1186/1471-2474-11-206.
12. FDA states verbatim that stem cell, stromal vascular fraction, umbilical cord blood, Wharton's jelly, amniotic fluid and exosome products 'have [not] been approved for the treatment of any orthopedic condition, such as osteoarthritis, tendonitis, disc disease, tennis elbow, back pain, hip pain, knee pain, neck pain, or shoulder pain.' The only FDA-approved stem cell products in the United States are blood-forming (hematopoietic progenitor) cells from umbilical cord blood, approved only for disorders of blood production, and there are currently NO FDA-approved exosome products.
   U.S. Food and Drug Administration — [Consumer Alert on Regenerative Medicine Products Including Stem Cells and Exosomes](https://www.fda.gov/vaccines-blood-biologics/consumers-biologics/consumer-alert-regenerative-medicine-products-including-stem-cells-and-exosomes). *FDA (Center for Biologics Evaluation and Research)*, 2020.
13. A 2026 meta-analysis of 21 studies (1,279 patients) found leukocyte-poor PRP augmentation at rotator cuff repair reduced structural retear risk (overall RR 0.74, 95% CI 0.55-0.99), with the benefit clearest in medium-sized tears (RR 0.68). Patient-reported outcomes did NOT improve consistently, publication-bias diagnostics indicated small-study effects (Egger p=0.017), and trim-and-fill adjustment moved the estimate to a non-significant RR 0.91 (0.69-1.19).
   Dunivan Q, et al. — [Leukocyte-poor platelet-rich plasma reduces retear risk after arthroscopic rotator cuff repair: a meta-analysis with mechanistic and economic evaluation.](https://pubmed.ncbi.nlm.nih.gov/41759819/). *J Shoulder Elbow Surg*, 2026. DOI: 10.1016/j.jse.2026.02.018.

## What if the shoulder won't quit aching?

If the shoulder keeps aching, QC Kinetix medical providers check it and discuss regenerative treatment, meaning non-surgical care such as platelet-rich plasma, or PRP, prepared there from your blood and put into the sore shoulder. The visit can cover what you've tried, what the exam found, and what the care may cost. Chandler works for much of Mesa, while Scottsdale may be closer from the north and northeast. Call (602) 837-PAIN or use the booking link when you're ready.

Book a free consultation: <https://shoulder.qckaz.com/?src=shoulderpainmesa.com>

---

Straight answers for a shoulder that won't settle.

Plain shoulder pain treatment Mesa answers about soreness, simple ways to help it, warning signs and nearby clinics.

Plain answers about shoulder aches, simple relief, urgent signs, and Mesa clinic routes.

This site is operated by the owners of the QC Kinetix Phoenix-area clinics, including the Chandler and Scottsdale offices described here, and the business benefits when readers book with those clinics.

© 2026 The Mesa Shoulder Ledger. General education for adults with shoulder concerns; urgent warning signs and personal diagnosis require medical care.